Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond
- PMID: 37024384
- DOI: 10.1016/j.hoc.2023.02.009
Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond
Abstract
This article provides an updated review of the management of oncogene-driven non-small cell lung cancer. The use of targeted therapies for lung cancer driven by EGFR, ALK, ROS1, RET, NTRK, HER2, BRAF, MET, and KRAS are discussed, both in the first-line setting and in the setting of acquired resistance.
Keywords: Non–small cell lung cancer; Oncogenes; Resistance; Targeted therapy.
Copyright © 2023 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous